Truist Financial Corp grew its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 13.9% in the 4th ...

IDEXX Laboratories, Inc.’s IDXX fourth-quarter performance was driven by the consistent strong performance of the Companion Animal Group (“CAG”) segment. Solid performance in the international markets ...

IDEXX Laboratories is poised for growth in the pet healthcare market. Check out why I see a 50% upside in IDXX stock by FY27.

Savant Capital LLC lowered its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 14.4% in the 4th ...

Shares of IDEXX Laboratories Inc. IDXX rallied 1.02% to $449.06 Tuesday, on what proved to be an all-around positive trading ...

Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion ...

subject to market conditions, equivalent to ~4% of current equity market capitalization. Price Action: IDXX stock is up 11.2% at $469.21 at last check Monday.

IDEXX LABS ($IDXX) is expected to release its quarterly earnings data on Monday, February 3rd before market open. Analysts are expecting revenue of $953,685,832 and ...

IDEXX Laboratories, Inc. IDXX has unveiled the IDEXX Cancer Dx ... development to positively boost market sentiment toward the stock. IDEXX currently has a market capitalization of $35.26 billion.